O. Kostek Et Al. , "Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer," CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.83, no.4, pp.735-742, 2019
Kostek, O. Et Al. 2019. Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer. CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.83, no.4 , 735-742.
Kostek, O., Yilmaz, E., Hacioglu, M. B., Demircan, N. C., Gokyer, A., UZUNOĞLU, S., ... TUNÇBİLEK, N.(2019). Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer. CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.83, no.4, 735-742.
Kostek, OSMAN Et Al. "Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer," CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.83, no.4, 735-742, 2019
Kostek, OSMAN Et Al. "Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer." CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.83, no.4, pp.735-742, 2019
Kostek, O. Et Al. (2019) . "Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer." CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.83, no.4, pp.735-742.
@article{article, author={OSMAN KÖSTEK Et Al. }, title={Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer}, journal={CANCER CHEMOTHERAPY AND PHARMACOLOGY}, year=2019, pages={735-742} }